conducted a study with CAFs isolated from stage IIIC OC patients in which they determined that CAFs, through the secretion of exosomes loaded with TGF-β, can promote various pro-tumor events such as migration, invasion, and EMT of OC cells through the activation of SMAD signaling pathway. The gene discussed is TGFB1; the disease is neoplasm.